Selected Reviews Since 2022
- TTP and history:
- Cataland SR et al. Thrombotic thrombocytopenic purpura: 100 years of research on Moschcowitz syndrome. Blood. 2024 Sep 12;144(11):1143-1152. PMID: 38958481
- George JN. Thrombotic Thrombocytopenic Purpura: From 1972 to 2022 and Beyond. Semin Thromb Hemost. 2022 Nov;48(8):926-936. PMID: 35793688
- TTP and pregnancy:
- Gounder P, Scully M. TTP and pregnancy. Br J Haematol. 2024 Oct;205(4):1288-1290. PMID: 39197429
- TTP and pathophysiology:
- Liu S, Zheng XL. Immune thrombotic thrombocytopenic purpura: pathogenesis and novel therapies: a narrative review. Ann Blood. 2023 Sep 30;8:26. PMID: 39100389
- Shaw RJ et al. The Highs and Lows of ADAMTS13 Activity. J Clin Med. 2024 Aug 30;13(17):5152. PMID 39274365
- DeYoung V et al. Mechanisms of ADAMTS13 regulation. J Thromb Haemost. 2022 Dec;20(12):2722-2732. PMID: 36074019
- TTP and diagnosis:
- Story CM et al. Medical consult: aHUS, TTP? How to distinguish and what to do. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):745-753. PMID: 38066937
- Siniard RC et al. Challenges in the diagnosis of thrombotic thrombocytopenic purpura. Expert Rev Hematol. 2023 Jul-Dec;16(11):861-869. PMID: 37767808
- Dimopoulos K. Laboratory investigation and diagnosis of thrombotic thrombocytopenic purpura. Crit Rev Clin Lab Sci. 2023 Dec;60(8):625-639. PMID: 37452521
- TTP and therapy:
- Zheng XL. Expert Rev Hematol. Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura. 2024 Jul;17(7):341-351. PMID: 38752747
- Seguí IG et al. Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons. Expert Rev Hematol. 2024 Jan-Mar;17(1-3):9-25. PMID: 38353182
- Patır P et al. Plasma cell-directed therapy strategies in immune-mediated thrombotic thrombocytopenic purpura (iTTP). Transfusion. 2024 Mar;64(3):536-545. PMID: 38235916
- Moroniti JJ et al. Targeted ADAMTS-13 replacement therapy for thrombotic thrombocytopenic purpura. J Thromb Haemost. 2024 Apr;22(4):896-904. PMID: 38142844
- Laurence J. Refining the standard of care in immune thrombotic thrombocytopenic purpura. Clin Adv Hematol Oncol. 2024 Oct;22(8):381-391. PMID: 39356816
- Kubo M, Matsumoto M. Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura. Int J Hematol. 2023 Mar;117(3):331-340. PMID: 36757521
- Akwaa F et al. How I treat immune-mediated thrombotic thrombocytopenic purpura after hospital discharge. Blood. 2022 Aug 4;140(5):438-444. PMID: 35667044
- Neurological complications of TTP:
- Shaw RJ, Dutt T. Mind and matter: The neurological complications of thrombotic thrombocytopenic purpura. Br J Haematol. 2022 Jun;197(5):529-538. PMID: 35277972
- TTP and pregnancy:
- Gounder P, Scully M. TTP and pregnancy. Br J Haematol. 2024 Oct;205(4):1288-1290. PMID: 39197429
- Drug-induced TTP:
- Scully M. A ‘needle in a haystack’: Drug-induced thrombotic thrombocytopenic purpura-Association or causality? Br J Haematol. 2023 May;201(4):599-601. PMID: 36661238
- HIV-associated TTP:
- Louw S et al. HIV-associated thrombotic thrombocytopenic purpura (HIV-TTP): A practical guide and review of the literature. HIV Med. 2022 Nov;23(10):1033-1040. PMID: 35373442